Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy

DOI10.1007/s11538-024-01329-6zbMATH Open1544.92082MaRDI QIDQ6597999

Zonghang Ren, Chenghang Li, Jinzhi Lei, Guiyu Yang

Publication date: 4 September 2024

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

zbMATH Keywords

mathematical modelimmunotherapytumor microenvironmentbladder cancercombination therapytargeted therapy

Mathematics Subject Classification ID

Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)

Cites Work

• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
• Modeling immunotherapy of the tumor -- immune interaction
• Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
• Stability analysis of delayed immune response BCG infection in bladder cancer treatment model by stochastic perturbations
• The role of exosomes in pancreatic cancer microenvironment
• A mathematical model of tumor-immune interactions
• Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy
• Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer
• A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor
• Modeling tumour heterogeneity of PD-L1 expression in tumour progression and adaptive therapy
• Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study

This page was built for publication: Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6597999)